These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies. Tracy JA; Dyck PJ Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243 [TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathy. Kuitwaard K; van den Berg LH; Vermeulen M; Brusse E; Cats EA; van der Kooi AJ; Notermans NC; van der Pol WL; van Schaik IN; van Nes SI; Hop WC; van Doorn PA J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1374-9. PubMed ID: 20587484 [TBL] [Abstract][Full Text] [Related]
8. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy. Markvardsen LH; Debost JC; Harbo T; Sindrup SH; Andersen H; Christiansen I; Otto M; Olsen NK; Lassen LL; Jakobsen J; Eur J Neurol; 2013 May; 20(5):836-42. PubMed ID: 23294032 [TBL] [Abstract][Full Text] [Related]
11. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA; Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948 [TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone. Lopate G; Pestronk A; Al-Lozi M Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853 [TBL] [Abstract][Full Text] [Related]
13. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary? Wadwekar V; Kalita J; Misra UK Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of azathioprine and methotrexate in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Mehreen S; Iftikhar S; Muhammad A; Aatif Siddique R; Shahid S Pak J Pharm Sci; 2023 Jul; 36(4(Special)):1361-1365. PubMed ID: 37606029 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Hughes RA; Donofrio P; Bril V; Dalakas MC; Deng C; Hanna K; Hartung HP; Latov N; Merkies IS; van Doorn PA; Lancet Neurol; 2008 Feb; 7(2):136-44. PubMed ID: 18178525 [TBL] [Abstract][Full Text] [Related]
18. An international multicenter efficacy and safety study of IqYmune in initial and maintenance treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy: PRISM study. Nobile-Orazio E; Pujol S; Kasiborski F; Ouaja R; Corte GD; Bonek R; Cocito D; Schenone A J Peripher Nerv Syst; 2020 Dec; 25(4):356-365. PubMed ID: 32808406 [TBL] [Abstract][Full Text] [Related]
19. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies. Dalakas MC J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy. Matsuda M; Hoshi K; Gono T; Morita H; Ikeda S J Neurol Sci; 2004 Sep; 224(1-2):29-35. PubMed ID: 15450768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]